Anika Therapeutics, Inc. Goodwill and Intangible Asset Impairment
Anika Therapeutics, Inc. (ANIK) reported Goodwill and Intangible Asset Impairment of $62.19 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2024-03-15
- Anika Therapeutics, Inc. goodwill and intangible asset impairment for fiscal 2023 was $62.19M.
- Anika Therapeutics, Inc. goodwill and intangible asset impairment for fiscal 2022 was $0.00.
- Anika Therapeutics, Inc. goodwill and intangible asset impairment for fiscal 2021 was $0.00.
| Period end | Goodwill and Intangible Asset Impairment 12 month |
|---|---|
| 2023-12-31 | $62.19M 10-K · filed 2024-03-15 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-15 |
| 2021-12-31 | $0.00 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |